SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003093
Filing Date
2021-11-04
Accepted
2021-11-04 16:41:22
Documents
62
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lbph-20210930.htm   iXBRL 10-Q 2737557
2 EX-31.1 lbph-ex31_1.htm EX-31.1 19948
3 EX-31.2 lbph-ex31_2.htm EX-31.2 19960
4 EX-32.1 lbph-ex32_1.htm EX-32.1 20673
5 GRAPHIC img7673250_0.jpg GRAPHIC 376622
  Complete submission text file 0000950170-21-003093.txt   11498296

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lbph-20210930_def.xml EX-101.DEF 162068
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20210930_lab.xml EX-101.LAB 380179
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20210930_pre.xml EX-101.PRE 291548
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lbph-20210930_cal.xml EX-101.CAL 41014
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20210930.xsd EX-101.SCH 42378
11 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20210930_htm.xml XML 2687127
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40192 | Film No.: 211380529
SIC: 2834 Pharmaceutical Preparations